Niagara Health Administering Third Shots For Additional Vulnerable Groups

Organization says third shot provides extra layer of protection for individuals with certain health conditions.

Niagara Health is now administering third COVID-19 shots to additional vulnerable populations. 

Starting today, Niagara residents in all of the following groups can get a third dose. 

• Those undergoing active treatment for solid tumors.
• Those who are in receipt of chimeric antigen receptor (CAR)-T-cell;
• Those with moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome);
• Stage 3 or advanced untreated HIV infection and those with acquired immunodeficiency syndrome; and
• Those undergoing active treatment with the following categories of immunosuppressive therapies: anti-B cell therapies (monoclonal antibodies targeting CD19, CD20 and CD22), high-dose systemic corticosteroids, alkylating agents, antimetabolites, or tumor-necrosis factor (TNF) inhibitors and other biologic agents that are significantly immunosuppressive.
• Transplant recipients (including solid organ transplant and hematopoietic stem cell transplants.
• Patients with hematological cancers (examples include lymphoma, myeloma, leukemia) on active treatment (chemotherapy, targeted therapies, immunotherapy) for malignant hematologic disorders
• Recipients of an anti-CD20 agent (e.g. rituximab, ocrelizumab, ofatumumab)
• Residents of high-risk congregate settings including long-term care homes, higher-risk licensed retirement homes and First Nations Elder Care Lodges.

As well, Niagara Health's clinic at the St. Catharines site will be closed on Sunday due to low bookings. 

Regular operations will return on Monday, September 20th, and booked and walk-in appointments will be accepted. 

To make an appointment, click here.